While Los Angeles is not facing a crisis of political leadership, it does confront a dearth of civic leadership.

The CHMP’s recommendation for ZURZUVAE will now be reviewed by the EC for marketing authorization in the European Union with a final decision expected in the third quarter of 2025. The U.S. FDA ...